Riemser Arzneimittel AG

https://www.riemser.de

RIEMSER Pharma GmbH, headquartered in Greifswald, Germany, is a midsize specialty pharmaceutical company which markets its products in Germany and worldwide. RIEMSER focuses principally on prescription-only human pharmaceuticals in selected therapeutic markets with high medical need, in particular Oncology, Anti-infectives and Dermatology. *

	Start	1990-01-01 established
	End	2015-02-26 renamed before
	Today	Riemser Pharma GmbH
	Successor	Riemser Pharma GmbH
	Industry	BIOTECH
	Person	Mehler, Michael (AXA 201208 CEO of Riemser Pharma before Actelion + Novartis)

	Region	Greifswald
	Country	Germany
	Street	7 An der Wiek
	City	17493 Greifswald, Insel Riems
	Tel	+49-38351-76-0
		Address record changed: 2020-12-02

Basic data	Employees	D: 101 to 500 (2012-08-21)
	Currency	EUR
	Annual sales	100,000,000 (sales revenues (2011) 2011-12-31)

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Register 650x200px

More documents for Esteve (Group)

[1] Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)